Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
about
Disease-modifying treatments for multiple sclerosis - a review of approved medicationsAutologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.Emerging immunopharmacological targets in multiple sclerosis.High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.Autologous hematopoietic stem cell transplantation (AHSCT) for aggressive multiple sclerosis - whom, when and how.Autologous hematopoietic cell transplantation in multiple sclerosis.Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow TranLong-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.Therapeutic management of severe relapses in multiple sclerosis.Cell Therapy for Multiple Sclerosis.Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis.Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosisIntense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis.Long-term follow-up more than 10 years after HSCT: a monocentric experience.Cell-based therapeutic strategies for multiple sclerosis.Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.Autologous haematopoietic stem cell transplantation for neurological diseases.Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis.Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis.NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.Updated views on autologous hematopoietic stem cell transplantation for treatment of multiple sclerosis.Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant.[Stem cell transplantation for multiple sclerosis. Hamburg experiences and state of international research].Zelldepletion und Myeloablation bei neuroimmunologischen Erkrankungen
P2860
Q26777329-4D832C4A-4D47-4732-8C21-6EB48555BDD4Q31075436-CD8174F6-0286-49B5-AE04-6C6DC0F09740Q34500124-4000DB62-D135-4D5A-BC94-04BB654AF43DQ37559970-7D277022-C135-483A-BB7F-19181FF1EE50Q37673801-FC9ACE8D-BE26-483C-B7CD-6CDC9869118DQ38268313-364CB698-1379-4512-845F-06EC5CF1F301Q38636103-4197F53E-E5F8-4C3E-829E-E8C56EA62A2DQ38818703-30ED5F1C-59B3-4C6D-A409-4482AEE6B6FAQ38837567-96A2539D-7DA4-4521-B6A3-785A0010E6C2Q38893873-9CC9B03F-99D5-4FFE-A9D1-4457970B94DCQ38939585-39356753-6EF0-4055-BE15-DCF2EB510CD0Q39026942-547D6261-BC36-4DD5-A8AE-85171C1987E6Q39233323-4217F9B3-241F-405F-BF16-10D8BFE178E8Q39378263-0140A3D4-6E1B-4181-BDAC-EBA17550EDDDQ40041536-987FD617-76B5-4D95-B326-89C699954A84Q40177200-00E472D8-2471-43C4-88DE-EFE262F8CFF4Q41010737-0F8C9AF4-722F-4A5F-B7BD-7F227538A633Q41355196-0004C225-988F-413F-AE1A-6A2E63D060B2Q42091679-9ABC97DC-7B87-4512-828A-D6340C82372BQ46301560-76E42749-88EE-4D23-8F2D-8C8E20A36449Q47261875-278EF362-324E-48B7-BEB3-AEC397DFED3DQ47885870-6E830D07-D56C-4823-ADE2-9CF5EF1EAA27Q48048274-253EE451-FA9B-4F4A-946C-425043F41770Q48136043-01B9BF1D-7A23-47B6-9230-741AD163EF1CQ48213823-8E58D046-454C-4BB4-A2BA-5F1D5BDBF00BQ48271331-BF985491-5EED-458C-A6E8-205E537A99A3Q48721170-83906762-80E7-4326-9EB1-345C534FAAA1Q48881267-ACBB161C-7FA6-4484-ABE6-0C4C20DF39CFQ52624498-8262E10E-4CC2-48C3-B6F0-CA5924B8FD0EQ52944830-64706CA2-4372-4799-991E-4F8C14A232DFQ57912843-3BC5C513-AEEB-4B90-AF03-84DCF8440E65
P2860
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Autologous haematopoietic stem ...... rosis: the Swedish experience.
@en
Autologous haematopoietic stem ...... rosis: the Swedish experience.
@nl
type
label
Autologous haematopoietic stem ...... rosis: the Swedish experience.
@en
Autologous haematopoietic stem ...... rosis: the Swedish experience.
@nl
prefLabel
Autologous haematopoietic stem ...... rosis: the Swedish experience.
@en
Autologous haematopoietic stem ...... rosis: the Swedish experience.
@nl
P2093
P2860
P50
P356
P1476
Autologous haematopoietic stem ...... erosis: the Swedish experience
@en
P2093
Anna Sandstedt
Bertil Uggla
Cecilia Isaksson
Claes Martin
Ellen Iacobaeus
Hans Hägglund
Jan-Erik Johansson
Kristina Carlson
Magnus Vrethem
Martin Gunnarsson
P2860
P304
P356
10.1136/JNNP-2013-307207
P407
P577
2014-02-19T00:00:00Z